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 Idiopathic infantile nystagmus (IIN), also referred to as
congenital nystagmus (CN), congenital “motor” nystagmus
(CMN), idiopathic congenital nystagmus (ICN), or congeni-
tal idiopathic nystagmus (CIN), is a genetically heterogeneous
form of developmental nystagmus that usually presents be-
tween birth and 6 months of age with an estimated annual
incidence of 1/20,000 [1]. IIN is a diagnosis of “primary” or
isolated nystagmus after exclusion of “secondary” nystagmus
associated with patent neurological disease (e.g. glioma, cor-
tical visual impairment), or identifiable sensory visual defects
including, opacities of the cornea, lens and vitreous, foveal
hypoplasia in albinism and aniridia, achromatopsia, retinal
dystrophies, and optic nerve hypoplasia. Classical IIN pre-
sents as conjugate, horizontal oscillations of the eyes, in pri-
mary or eccentric gaze (i.e. uniplanar), often with a preferred
head turn or tilt that is associated with a fixed “null-point”
where the nystagmus intensity is dampened [2]. Other associ-
ated features are restricted to strabismus (esotropia), refrac-
tive error (astigmatism), and occasionally head nodding. Eye
movement recordings reveal that classical IIN is predominantly
a horizontal jerk waveform, with a “diagnostic” accelerating
velocity slow phase. However, pendular and triangular wave-
forms may also present. Less often, IIN may exhibit predomi-
nantly vertical or torsional (elliptical) waveforms. Beyond
exclusion of sensory defect nystagmus and neurological nys-
tagmus, IIN must also be carefully differentiated from certain
other forms of infantile nystagmus including, fusional malde-
velopment nystagmus syndrome or latent fixation nystagmus,
spamus nutans syndrome, which is characterized by asymetric
or unilateral nystagmus, and periodic alternating nystagmus,
which resembles IIN except that the null-point shifts position
in a regular cyclic pattern [2].
All three classical types of Mendelian inheritance have
been reported for IIN (Table 1); however, X-linked inherit-
ance is likely the most common form [3]. Two loci for autoso-
mal dominant IIN have been identified on 6p12 (NYS2) [4,5]
and 7p11.2 (NYS3) [6,7] with tentative evidence from haplo-
type analysis for additional loci [8,9]. Indeed, a third locus for
autosomal donminant nystagmus (NYS4) has been mapped
to 13q31-q33 [10,11]; however NYS4 involves
vestibulocerebellar dysfunction and is clinically distinct from
IIN. X-linked IIN has been associated with two physically
independent loci (both symbolized NYS1) that map to Xp11.4-
p11.3 [8,12] and Xq26.3-q27.1 [13-18]. In addition, a locus
for infantile periodic alternating nystagmus (NYS5), which
often accompanies albinism, has been assigned to chromo-
some X [19]. Here we define an interval on Xq for IIN and
identify a mutation in the gene encoding a putative cytoskeletal
protein referred to as four-point-one (4.1), ezrin, radixin,
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Purpose: Infantile nystagmus is a clinically and genetically heterogeneous eye movement disorder. Here we map and
identify the genetic mutation underlying X-linked idiopathic infantile nystagmus (XL-IIN) segregating in two Caucasian-
American families.
Methods: Eye movements were recorded using binocular infrared digital video-oculography. Genomic DNA was pre-
pared from blood or buccal-cells, and linkage analysis was performed using short tandem repeat (STR) and single nucle-
otide polymorphism (SNP) markers. Pedigree and haplotype data were managed using Cyrillic, and LOD scores calcu-
lated using MLINK. Mutation profiling of PCR-amplified exons was performed by dye-terminator cycle-sequencing and
analyzed by automated capillary electrophoresis.
Results: Video-oculography of affected males recorded conjugate, horizontal, pendular nystagmus with increasing-ve-
locity waveforms in primary gaze converting to jerk nystagmus in eccentric gaze. Linkage analysis detected significantly
positive two-point LOD scores (Z) at markers DXS8078 (Z=4.82, recombination fraction [θ]=0) and DXS1047 (Z=3.87,
θ=0). Haplotyping indicated that the IIN locus mapped to the physical interval DXS8057-(11.59 Mb)-rs6528335 on
Xq25-q26. Sequencing of positional-candidate genes detected a c.425T>G transversion in exon-6 of the gene for FERM
domain containing-7 (FRMD7) that cosegregated with affected and carrier status. In addition, the same change was found
to cosegregate with IIN in a genetically unrelated family but was not detected in 192 control individuals.
Conclusions: The c.425T>G change is predicted to result in the missense substitution of the phylogenetically conserved
leucine at codon 142 for an arginine (p.L142R), and supports a causative role for FRMD7 mutations in the pathogenesis of
XL-IIN.
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moesin (FERM) domain containing-7 (FRMD7), which was
recently associated with XL-IIN [20-24].
METHODS
Participants and ophthalmic exams:  Ethical approval for this
study was obtained from the Washington University Human
Research Protection Office, and written informed consent was
provided by all participants prior to enrollment in accordance
with the tenets of the Declaration of Helsinki. Participants were
ascertained from the ophthalmic records at St. Louis Children’s
Hospital. Blood samples were collected by venepuncture
(about 20 ml) or finger-stick (about 200 µl) into K2EDTA
vacutainer or microtainer tubes (BD Biosciences, San Jose,
CA), respectively. Buccal-cell samples were self-collected into
50 ml conical tubes (Falcon; BD Biosciences) after vigorous
rinsing (about 30 s) with Scope (about 20 ml) mouthwash
(Procter & Gamble, Cincinnati, OH).
Ophthalmologic examination included: best-corrected
visual acuity in each eye (using optotypes at 33 cm and 6 m),
cycloplegic refraction, visual field testing, pupillary exami-
nation for isocoria and afferent defects, slit lamp examination
with retro-illumination, ocular motor examination for strabis-
mus (cover testing), binocular sensorial testing of fusion and
stereopsis (Titmus and Randot tests), and dilated funduscopic
examination of the optic nerves, maculae, and peripheral reti-
nae. Care was taken to verify absence of signs of ocular or
oculocutaneous albinism, e.g. iris transillumination defects,
foveal hypoplasia and fundus hypopigmentation. Pattern vi-
sually-evoked potentials were recorded (using an array of elec-
trodes across the occiput) to rule-out the abnormal chiasmal
decussation responses characteristic of albinotic or achiasmatic
retino-geniculo-striate visual pathways. Nystagmus wave-
forms were recorded using binocular digitial, infra-red
oculography (3D VOG, SensoMotoric Instruments, Teltow,
Germany) at a spatiotemporal resolution of 0.02°/60 Hz.
Genotyping and linkage analysis:  Genomic DNA was
extracted from peripheral blood leukocytes using the QIAamp
DNA blood maxi kit (Qiagen, Valencia, CA) or from buccal-
cell samples using the Puregene Mouthwash kit (Qiagen), and
quantified by absorbance at 260 nm (GeneQuant pro; GE
Healthcare, Waukesha, WI). X-chromosome short tandem re-
peat (STR) markers from the combined \Genethon, Marshfield,
and deCODE genetic linkage maps (National Center for Bio-
technology Information [NCBI]) were polymerase chain re-
action (PCR) amplified with M13-tailed primers [25] in the
presence of an IRDye800 labeled M13-universal primer (Li-
Cor, Lincoln, NE), and detected using a 4200 DNA analyzer
running Gene ImagIR software (Li-Cor) as described previ-
ously [26]. Single nucleotide polymorphism (SNP) markers
from the SNP database (dbSNP, NCBI), were PCR amplified
with M13-tailed primers designed from the flanking sequence
(250-500 bp apart) using appropriate software (e.g.
PrimerQuest, idtdna.com), and scored by sequencing essen-
tially as described for mutation analysis below. Pedigree and
haploptype data were managed using Cyrillic (v.2.1) software
(FamilyGenetix Ltd., Reading, UK), and two-point LOD scores
(Z) calculated using the MLINK sub-program from the LINK-
AGE (5.1) package of programs [27] assuming X-linked domi-
nant inheritance with 45% penetrance in females. Marker al-
lele frequencies were assumed to be equal, and a gene fre-
quency of 0.0001 was assumed for the disease locus.
Mutation analysis:  Genomic sequence for FRMD7 was
obtained from the Entrez human genome browser (NCBI), and
gene-specific M13-tailed PCR primers were selected from the
NCBI resequencing amplicon (RSA) probe database (NCBI).
Genomic DNA (1 ng/µl, 10-50 µl reactions), was amplified
(35-40 cycles) in a GeneAmp 9700 thermal cycler using
AmpliTaq Gold Universal PCR Master Mix (Applied
Biosystems, Foster City, CA) and gene-specific primers (25
pmol). Resulting PCR amplicons (about 250-500 bp) were
either enzyme-purified with ExoSAP-IT (USB Corporation,
Cleveland, OH) or gel-purified with the QIAquick gel-extrac-
tion kit (Qiagen). Purified amplicons were direct cycle-se-
quenced in both directions with BigDye Terminator Ready
Reaction Mix containing M13 forward or reverse sequencing
primers then ethanol precipitated and detected by capillary
electrophoresis on a 3130xl Genetic Analyzer running Se-
quence Analysis (v 5.2) software (Applied Biosystems).
For restriction fragment length analysis, exon-6 of
FRMD7 was amplified from pedigree DNA and from the Hu-
man Random Control DNA Panels 1 and 2 (Sigma-Aldrich,
St. Louis, MO) as described for sequencing above, then di-
gested (37 °C for 1 h) with Bsp1286I (5 U/µl; New England
BioLabs, Ipswich, MA), and visualized (302 nm) on 2% aga-
rose/0.05% ethidium bromide gels.
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TABLE 1. A GENETIC MAP OF INHERITED NYSTAGMUS
Genetic loci that have been mapped for inherited forms of developmental nystagmus. AD denotes autosomal dominant inheritance. XL
denotes X-linked inheritance. XLD(IP) denotes X-linked dominant inheritance with incomplete penetrance in females. Note that autosomal
recessive nystagmus (OMIM 257400) has not been mapped.
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Figure 1. Familial X-linked idiopathic infantile nystagmus (IIN).  A: Pedigree and haplotype analysis of family W showing segregation of 7
STR and 1 SNP marker on Xq, listed in descending order from the centromere. Individuals marked with a sharp (hash mark) underwent
detailed ophthalmic examination. B: Pedigree and haplotype analysis of family M showing allelic differences with family W at markers
DXS1047, DXS8094, and DXS1062. C: Ideogram of chromosome-X showing the cytogenetic locations of markers defining the IIN locus in
this study (red) and the NYS1 (FRMD7) locus on Xq. The ocular albinism-1 (OA1, GPR143) and NYS1 loci on Xp are also indicated.
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RESULTS
Pedigree structures:  We studied two extended Caucasian-
American families (W and M) diagnosed with IIN in the ab-
sence of detectable sensory visual defects or neurological ab-
normalities (Figure 1). In family W, we ascertained about 50
members spanning 5-generations (Figure 1A), including 7 af-
fected males (2 deceased), and 6 affected females (1 deceased).
X-linked inheritance was supported by the absence of father-
to-son transmission and the presence of unaffected (carrier)
mother-to-son transmission. Of the 9 obligate female carriers
in generation-3 (daughters of affected fathers), 4 were affected
(III:5, III:12, III:14, III:20) indicative of X-linked dominant
inheritance with incomplete penetrance (about 45%) among
females. Skewed X-inactivation is an attractive explanation
for such variable penetrance; however, its role in IIN is con-
troversial [23].
In addition, we ascertained 9 members of family M span-
ning 3-generations (Figure 1B) including 2 affected males
(III:1, III:2). Transmission was consistent with X-linked in-
heritance. However, the pedigree was of insufficient size to
exclude the possibility of autosomal dominant inheritance with
incomplete penetrance or autosomal recessive inheritance.
Ocular phenotypes:  Detailed ophthalmic examination of
14 members from family W (Figure 1) including 7 males (3
affected) and 7 females (1 affected) was undertaken by one of
us (L.T.). All examined individuals in family W (age range 8-
66 years) displayed clinically normal color vision, pupillary
light reflexes, anterior segment, retina (including fovea), and
optic nerve head. Visual acuity (best corrected with refrac-
tion) was 20/40 in both eyes of affected family members;
Randot stereopsis was normal; and cycloplegic refractive er-
rors showed moderate myopic astigmatism OU (spherical 3/4
-4.50 D; cylinder 3/4 4.00 D). Unaffected family members
had moderate myopia and best corrected acuities of 20/20 OU.
No iris transillumination defects were present, and the absence
of ocular albinism was confirmed in one affected male (IV:17)
by the presence of normal pattern visual evoked potentials
(data not shown). IIN was diagnosed before 6 months of age
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Figure 2. Nystagmus waveforms of affected male IV:6 (8 years old)
in family W.  A: Movie of eye movement recordings of affected male
IV:6 (8 years of age) from family W, using binocular infrared digital
video-oculography. (There is a quicktime movie of this figure in the
online version of this article. A representative frame is included here).
B: Conjugate, pendular-and-increasing-velocity waveform in right
(red) and left (blue) eye when fixating stationary target at straight-
ahead (primary, 0°) gaze. Note very-low-velocity rounded epochs of
brief foveation during each pendular cycle. C: Nystagmus converts
to jerk waveform in both eyes when required to fixate a target in
eccentric (16° right) gaze. Note that the slide bar at the bottom of the
quicktime movie can be used to manually control the flow of the
movie. If you are unable to view the movie, a representative frame is
included below.  This animation requires Quicktime 6 or later.
Quicktime is available as a free download.   
2236
in 3 males (II:5, IV:6, IV:17) and 1 female (III:20) and an
abnormal head turn (left 20-50°) was evident in all four af-
fected individuals, consistent with a null-zone. Infrared eye
movement recordings were obtained from two affected males
(IV:6, IV:17). Both patients were found to have conjugate,
horizontal nystagmus (see movie in Figure 2A), and the oscil-
lation was consistent with a combination of pendular and jerk
waveforms (Figure 2B). Similar ophthalmic examination and
testing of the male proband (III:1) in family M (Figure 1B)
was consistent with a diagnosis of “non-albinotic” IIN, ac-
companied by a mild left head turn and occasional head oscil-
lations.
Linkage to Xq:  In order to confirm X-linked inheritance
in family W, we genotyped 38 relatives (Figure 1A) including
5 affected males, 5 affected females, 6 carrier females, 17
unaffected individuals and 5 spouses with STR markers span-
ning the nystagmus loci previously mapped on Xp and Xq.
After exclusion of the Xp locus with marker DXS8012 (Z=-
1.06, θ=0.05), we obtained significant evidence of linkage
(Table 2) to the Xq locus (NYS1) at markers DXS8078
(Z=4.82, θ=0.00), DXS1047 (Z=3.87, θ=0.00), and DXS8033
(Z=3.69, θ=0.00).
Haplotyping with STR and SNP markers detected 10 re-
combinant individuals within pedigree W (Figure 1A). First,
2 unaffected females (II:8, IV:12) and 2 unaffected males
(III:21, IV:5) were recombinant proximally at DXS8057. Sec-
ond, 2 affected males (II:5, IV:17), 1 affected female (III:20),
2 carrier females (III:17, III:18), and 2 unaffected females (II:8,
IV:14) were obligate recombinants distally at rs6528335. How-
ever, no further recombination events were detected at inter-
vening markers, indicating that the IIN locus lay in the physi-
cal interval, DXS8057-(11.59 Mb)-rs6528335 on Xq25-q26
(Figure 1C). Family M had insufficient meioses to provide
independent evidence of linkage to the Xq interval; however,
haplotype analysis indicated that family M was genetically
unrelated to family W (Figure 1B).
Mutation in FRMD7: Our IIN interval contained about
105 positional-candidate genes (NCBI map viewer; build 36),
including the 12-exon gene now symbolized FRMD7 (GeneID:
90167; formerly LOC90167). Prior to the identification of
FRMD7 [20], we had excluded the presence of coding or splice-
site mutations in 5 other candidate genes (GPR119, MBNL3,
CXX1, ZNF75, TMEM32) with expressed sequence tags (ESTs)
in eye and/or brain (data not shown). Subsequent resequencing
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TABLE 2. TWO-POINT LOD SCORES (Z) FOR LINKAGE BETWEEN THE IIN LOCUS IN FAMILY W AND MARKERS ON CHROMOSOME X
Z values for markers on Xq listed in physical order, measured in megabases (Mb), from the short-arm telomere (Xp-tel). The maximum Z
values (Zmax) occurred at marker DXS8078, and at the c.425T>G transversion in exon-6 of FRMD7. θ=recombination fraction.
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Figure 3. Mutation analysis of FRMD7.  A: Sequence trace of the wild type allele, showing translation of leucine (L) at codon 142 (CTG). B:
Sequence trace of the heterozygous mutant allele, showing the c.425T>G transversion (denoted as K by the International Union of Pure and
Applied Chemistry [IUPAC] code) that is predicted to result in the missense substitution of arginine (R) for leucine at codon 142 (p.L142R).
C: Sequence trace of the hemizygous mutant allele showing translation of arginine (R) at codon 142 (CGG). D-E: Restriction-fragment-length
analysis showing gain of a Bsp1286I site (5'-GGGCA/C) that cosegregates only with affected and carrier individuals hemizygous or heterozy-
gous for the c.425T>G transversion (197/184 bp) in family W (D) and family M (E). F: Amino acid sequence alignment of human FRMD7 and
orthologs from other species, showing phylogenetic conservation of p.L142. G: Exon organization and mutation profile of FRMD7. Codons
are numbered below each exon. So far, more than 30 mutations have been reported [20-24]. Note the synonymous p.V84V polymorphism
(c.252G>A) creates a cryptic splice acceptor-site in exon 4 resulting in missplicing [20].
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of FRMD7 in family W detected a hemizygous c.425T>G
transversion in exon-6 of FRMD7 (Figure 3) in two affected
males (II:5, IV:6) that was not present in an unaffected male
(III:1). The same heterozygous change was also present in an
affected female (III:14). Surprisingly, in family M we identi-
fied the same hemizygous and heterozygous change in the af-
fected proband (III:1) and his carrier mother (II:4), respec-
tively. In addition, we detected normal allelic variations at 6
SNPs spanning FRMD7 (Table 3) that were not present in fam-
ily W, confirming that the families were genetically unrelated.
The c.425T>G transversion introduced an adjacent
Bsp1286 I restriction-enzyme site and allele-specific restric-
tion-fragment-length analysis confirmed that the G-allele
cosegregated with affected and carrier individuals in both fami-
lies W and M, but was not present in unaffected relatives (Fig-
ure 3D,E). Furthermore, when we tested the c.425T>G trans-
version as a biallelic marker in Family W, with a notional al-
lelic frequency of 1%, in a two-point LOD score analysis of
the IIN locus (Table 2) we obtained further compelling evi-
dence of linkage (Z=4.99, θ=0). In addition, we confirmed
that the c.425T>G transversion was not listed in dbSNP
(NCBI), and excluded it as a SNP in a panel of 192 normal
unrelated individuals (288 X-chromosomes) using Bsp1286 I
restriction analysis (data not shown). While it is possible that
an undetected mutation lay elsewhere within the disease-hap-
lotype interval, our genotype data in families W and M strongly
suggested that the c.425T>G transversion in exon-6 of FRMD7
represented a causative mutation rather than a benign SNP in
linkage disequilibrium with the XL-IIN phenotype.
The c.425T>G transversion occurred at the second base
of codon 142 (CTG>CGG), and was predicted to result in a
leucine-to-arginine missense substitution (p.L142R) at the level
of protein translation. Cross-species alignment of FRMD7
amino-acid sequences in the Entrez protein database using
ClustalW revealed that p.L142 is phylogenetically conserved
from zebrafish to man (Figure 3F). Moreover, the predicted
p.L142R substitution reflected a non-conservative amino acid
change, with the neutral hydrophobic side-group of leucine
replaced by the basic side-group of arginine. Position-specific
score matrix analysis, using the PSSM, showed a decline in
score from +4 to -2 (Table 4) confirming that the predicted
p.L142R substitution occurred less frequently than expected
in proteins with the conserved FERM domain (Conserved
Domain Database, pfam00373), further raising the likelihood
of functional consequences.
DISCUSSION
 In this study, we have mapped an interval for XL-IIN
(DXS8057-[about 11.6 Mb]-rs6528335) to the NYS1 locus
on Xq25-q26, and identified a missense mutation in FRMD7
(c.425T>G, p.L142R). Our disease interval overlaps that de-
scribed recently (DXS1047-[about 7.5 Mb]-DXS1041) [20],
and when combined these data refine the NYS1 locus to
DXS1047-(about 6.1 Mb)-rs6528335. The p.L142R mutation
was detected in two genetically unrelated Caucasian-Ameri-
can families, and has also has been described in a family of
Irish ancestry [20], providing further evidence for FRMD7
mutations in the pathogenesis of XL-IIN.
FRMD7 encodes a 714 amino acid protein belonging to
the FERM domain super-family of proteins, which mediate
linkage of plasma-membrane proteins to the cortical-cytosk-
eleton [28]. Interestingly, FRMD7 is evolutionarily related to
the FERM, Rho guanine-nucleotide exchange factor, plekstrin
homology domain proteins, FARP1 and FARP2, with all three
proteins sharing about 50% identity within the FERM domain.
So far, most of the mutations reported in FRMD7 reside in
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TABLE 3. FRMD7 SEQUENCE VARIATIONS DETECTED IN FAMILY M
Single nucleotide polymorphisms (SNPs) detected during
resequencing of the FRMD7 gene in family M. All 6 SNPs were
found in the heterozygous state. The asterisk indicates that the refer-
ence allele is shown on the left. The SNPs in exon 2 and exon 12
resulted in synonymous amino acid changes at serine 23 and isoleu-
cine 511, respectively. IVS denotes intervening (intron) sequence.
UTR denotes untranslated region.
TABLE 4. POSITION SPECIFIC SCORE MATRIX (PSSM) ANALYSIS OF THE PREDICTED P.L142R SUBSTITUTION IN FRMD7
Differences in the physico-chemical properties of leucine (L) and arginine (R) are consistent with a nonconservative substitution. The negative
PSSM value indicates that arginine substitutes for leucine at position 142 less frequently than expected among proteins containing the con-
served FERM domain.
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exons 1-11 (Figure 3G), which encode the FERM-domain and
the FERM-adjacent domain [20-22]. The FERM-domain is a
protease-resistant region comprising 200-300 amino acids
(about 30 kDa), arranged in a globular 3-lobed or cloverleaf-
like structure usually located near the NH2-terminus, which
binds a variety of membrane protein and lipid ligands [29].
Similarly, the FERM-adjacent (FA) domain is a protease-re-
sistant region of about 60 amino acids (about 16 kDa), juxta-
posed on the COOH-terminal side of the FERM domain, and
is believed to act as a regulator of the latter’s protein/lipid
binding activity [30].
FRMD7 is expressed in most adult human tissues, and
has been detected in the developing neuroretina and regions
of the embryonic brain known to control eye movement [20];
however, its precise function remains unknown. Interestingly,
FARP1 has been implicated in the regulation of microfilament
organization [31], and FARP2 has been shown to be involved
in neurite re-modeling and axonal repulsion [32,33], suggest-
ing that FRMD7 may also perform a dynamic neuro-
cytoskeletal function. In addition to enhanced diagnostic test-
ing and genetic counseling for IIN in a clinical setting, contin-
ued studies of FRMD7 will provide new insights regarding
the molecular control of eye movement and the development
of binocular vision.
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